Publications by authors named "Sylvie Neuville"
Article Synopsis
- Patients on maintenance hemodialysis typically have a weaker immune response to vaccinations, making it important to identify factors that affect their response to the BNT162b2 mRNA (Pfizer-BioNTech) vaccine.
- In a study involving 252 patients with a mean age of 71.9 years, factors such as immunosuppressive therapy and low baseline albumin levels were linked to a reduced likelihood of developing antibodies after vaccination.
- Results showed that about 90% of these patients did produce specific antibodies, but older age and certain health conditions increased the risk of poor response; hence, regular serological monitoring is recommended for timely booster doses.
